Parnassus Investments LLC raised its stake in Boston Scientific Co. (NYSE:BSX – Free Report) by 26.6% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,711 shares of the medical equipment provider’s stock after acquiring an additional 2,038 shares during the quarter. Parnassus […]
Bank of Nova Scotia raised its position in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 164.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 521,456 shares of the medical equipment provider’s stock after purchasing […]
Edmond DE Rothschild Holding S.A. raised its holdings in shares of Boston Scientific Co. (NYSE:BSX – Free Report) by 107.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 687,832 shares of the medical equipment provider’s stock after purchasing an additional 356,510 shares during the […]
StockNews.com upgraded shares of Boston Scientific (NYSE:BSX – Free Report) from a hold rating to a buy rating in a report issued on Thursday morning. Other equities research analysts have also issued reports about the stock. Barclays lifted their price target on shares of Boston Scientific from $70.00 to $78.00 and gave the company an […]
Boston Scientific (NYSE:BSX – Free Report) had its price objective boosted by Citigroup from $85.00 to $87.00 in a research note issued to investors on Wednesday, Benzinga reports. Citigroup currently has a buy rating on the medical equipment provider’s stock. Several other research firms have also recently weighed in on BSX. StockNews.com cut Boston Scientific […]